GSE176008 4 V 1 AZACITIDINE HUMAN UP (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with .

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with .

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with .

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with .

Results found

Linked to

 

Label

Description

 

Gene

cell division cycle 20

Gene

DnaJ heat shock protein family (Hsp40) member A3

Gene

heat shock protein family A (Hsp70) member 8

Gene

IKAROS family zinc finger 1

Gene

E2F transcription factor 2

Gene

joining chain of multimeric IgA and IgM

Gene

proliferating cell nuclear antigen

Gene

LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated

Gene

niban apoptosis regulator 1

Gene

Rho associated coiled-coil containing protein kinase 1

  • Gene

    cell division cycle 20


  • Gene

    DnaJ heat shock protein family (Hsp40) member A3


  • Gene

    heat shock protein family A (Hsp70) member 8


  • Gene

    IKAROS family zinc finger 1


  • Gene

    E2F transcription factor 2


  • Gene

    joining chain of multimeric IgA and IgM


  • Gene

    proliferating cell nuclear antigen


  • Gene

    LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated


  • Gene

    niban apoptosis regulator 1


  • Gene

    Rho associated coiled-coil containing protein kinase 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.